Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027

Quick Summary:

In the dynamic and rapidly progressing world of healthcare, staying ahead of emerging trends is paramount, especially in regards to the rapidly increasing market of hematopoietic stem cells transplantation (HSCT). With a forthcoming sustained growth forecasted, this report delivers a comprehensive and thoroughly researched insight into the HSCT market, offering a holistic analysis including market size, forecast, key trends, drivers and challenges surrounding this developing field.

Technological advancements, rising investment in regenerative medicine, and increased number of HSCT are stimulating market growth, while other significant factors influencing the market include the growing demand for personalized medicine, decreased morbidity and mortality rates, and the advent of cord blood banking. Our analysis diligently segments the market by application, type, and geographical landscape, providing an exhaustive outlook in all aspects of the HSCT sphere. This study is a pivotal resource to assist in refining strategies and leveraging upcoming growth opportunities in the HSCT market.

The hematopoietic stem cells transplantation (HSCT) market is forecasted to grow by $2383.61 mn during 2022-2027, accelerating at a CAGR of 6.5% during the forecast period. The report on the hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of technologically advanced equipment, increasing investments in field of regenerative medicines, and rising number of HSCT.

The hematopoietic stem cells transplantation (HSCT) market is segmented as below:

By Application

Bone marrow transplant
Peripheral blood stem cell transplant
Cord blood transplant

By Type

Autologous HSCT
Allogeneic HSCT

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing demand for personalized medicine as one of the prime reasons driving the hematopoietic stem cells transplantation (HSCT) market growth during the next few years. Also, decreasing morbidity and mortality rate and advent of cord blood banking will lead to sizable demand in the market.

The report on the hematopoietic stem cells transplantation (HSCT) market covers the following areas:

Hematopoietic stem cells transplantation (HSCT) market sizing
Hematopoietic stem cells transplantation (HSCT) market forecast
Hematopoietic stem cells transplantation (HSCT) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematopoietic stem cells transplantation (HSCT) market vendors that include Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., ThermoGenesis Holdings Inc., and AllCells Corp. Also, the hematopoietic stem cells transplantation (HSCT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Bone marrow transplant - Market size and forecast 2022-2027
Exhibit 34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
6.4 Peripheral blood stem cell transplant - Market size and forecast 2022-2027
Exhibit 38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
6.5 Cord blood transplant - Market size and forecast 2022-2027
Exhibit 42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 47: Chart on Type - Market share 2022-2027 (%)
Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 49: Chart on Comparison by Type
Exhibit 50: Data Table on Comparison by Type
7.3 Autologous HSCT - Market size and forecast 2022-2027
Exhibit 51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
7.4 Allogeneic HSCT - Market size and forecast 2022-2027
Exhibit 55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 59: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 AllCells Corp.
Exhibit 108: AllCells Corp. - Overview
Exhibit 109: AllCells Corp. - Product / Service
Exhibit 110: AllCells Corp. - Key offerings
12.4 Athersys Inc.
Exhibit 111: Athersys Inc. - Overview
Exhibit 112: Athersys Inc. - Product / Service
Exhibit 113: Athersys Inc. - Key offerings
12.5 Beike Biotechnology Co. Ltd.
Exhibit 114: Beike Biotechnology Co. Ltd. - Overview
Exhibit 115: Beike Biotechnology Co. Ltd. - Product / Service
Exhibit 116: Beike Biotechnology Co. Ltd. - Key offerings
12.6 bluebird bio Inc.
Exhibit 117: bluebird bio Inc. - Overview
Exhibit 118: bluebird bio Inc. - Product / Service
Exhibit 119: bluebird bio Inc. - Key offerings
12.7 Cellular Biomedicine Group Inc.
Exhibit 120: Cellular Biomedicine Group Inc. - Overview
Exhibit 121: Cellular Biomedicine Group Inc. - Product / Service
Exhibit 122: Cellular Biomedicine Group Inc. - Key offerings
12.8 FUJIFILM Corp.
Exhibit 123: FUJIFILM Corp. - Overview
Exhibit 124: FUJIFILM Corp. - Business segments
Exhibit 125: FUJIFILM Corp. - Key news
Exhibit 126: FUJIFILM Corp. - Key offerings
Exhibit 127: FUJIFILM Corp. - Segment focus
12.9 Gamida Cell Ltd.
Exhibit 128: Gamida Cell Ltd. - Overview
Exhibit 129: Gamida Cell Ltd. - Product / Service
Exhibit 130: Gamida Cell Ltd. - Key offerings
12.10 Lineage Cell Therapeutics Inc.
Exhibit 131: Lineage Cell Therapeutics Inc. - Overview
Exhibit 132: Lineage Cell Therapeutics Inc. - Product / Service
Exhibit 133: Lineage Cell Therapeutics Inc. - Key offerings
12.11 Lonza Group Ltd.
Exhibit 134: Lonza Group Ltd. - Overview
Exhibit 135: Lonza Group Ltd. - Business segments
Exhibit 136: Lonza Group Ltd. - Key news
Exhibit 137: Lonza Group Ltd. - Key offerings
Exhibit 138: Lonza Group Ltd. - Segment focus
12.12 MEDIPOST Co. Ltd.
Exhibit 139: MEDIPOST Co. Ltd. - Overview
Exhibit 140: MEDIPOST Co. Ltd. - Product / Service
Exhibit 141: MEDIPOST Co. Ltd. - Key offerings
12.13 Merck and Co. Inc.
Exhibit 142: Merck and Co. Inc. - Overview
Exhibit 143: Merck and Co. Inc. - Business segments
Exhibit 144: Merck and Co. Inc. - Key news
Exhibit 145: Merck and Co. Inc. - Key offerings
Exhibit 146: Merck and Co. Inc. - Segment focus
12.14 Mesoblast Ltd.
Exhibit 147: Mesoblast Ltd. - Overview
Exhibit 148: Mesoblast Ltd. - Product / Service
Exhibit 149: Mesoblast Ltd. - Key offerings
12.15 Sanofi SA
Exhibit 150: Sanofi SA - Overview
Exhibit 151: Sanofi SA - Business segments
Exhibit 152: Sanofi SA - Key news
Exhibit 153: Sanofi SA - Key offerings
Exhibit 154: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 ThermoGenesis Holdings Inc.
Exhibit 159: ThermoGenesis Holdings Inc. - Overview
Exhibit 160: ThermoGenesis Holdings Inc. - Product / Service
Exhibit 161: ThermoGenesis Holdings Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 162: Inclusions checklist
Exhibit 163: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 164: Currency conversion rates for US$
13.4 Research methodology
Exhibit 165: Research methodology
Exhibit 166: Validation techniques employed for market sizing
Exhibit 167: Information sources
13.5 List of abbreviations
Exhibit 168: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global hematopoietic stem cells transplantation (HSCT) market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Bone marrow transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Bone marrow transplant - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Peripheral blood stem cell transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Peripheral blood stem cell transplant - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Cord blood transplant - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Cord blood transplant - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Application ($ million)
Exhibits 47: Chart on Type - Market share 2022-2027 (%)
Exhibits 48: Data Table on Type - Market share 2022-2027 (%)
Exhibits 49: Chart on Comparison by Type
Exhibits 50: Data Table on Comparison by Type
Exhibits 51: Chart on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Autologous HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Autologous HSCT - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Allogeneic HSCT - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Allogeneic HSCT - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by Type ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: AllCells Corp. - Overview
Exhibits 109: AllCells Corp. - Product / Service
Exhibits 110: AllCells Corp. - Key offerings
Exhibits 111: Athersys Inc. - Overview
Exhibits 112: Athersys Inc. - Product / Service
Exhibits 113: Athersys Inc. - Key offerings
Exhibits 114: Beike Biotechnology Co. Ltd. - Overview
Exhibits 115: Beike Biotechnology Co. Ltd. - Product / Service
Exhibits 116: Beike Biotechnology Co. Ltd. - Key offerings
Exhibits 117: bluebird bio Inc. - Overview
Exhibits 118: bluebird bio Inc. - Product / Service
Exhibits 119: bluebird bio Inc. - Key offerings
Exhibits 120: Cellular Biomedicine Group Inc. - Overview
Exhibits 121: Cellular Biomedicine Group Inc. - Product / Service
Exhibits 122: Cellular Biomedicine Group Inc. - Key offerings
Exhibits 123: FUJIFILM Corp. - Overview
Exhibits 124: FUJIFILM Corp. - Business segments
Exhibits 125: FUJIFILM Corp. - Key news
Exhibits 126: FUJIFILM Corp. - Key offerings
Exhibits 127: FUJIFILM Corp. - Segment focus
Exhibits 128: Gamida Cell Ltd. - Overview
Exhibits 129: Gamida Cell Ltd. - Product / Service
Exhibits 130: Gamida Cell Ltd. - Key offerings
Exhibits 131: Lineage Cell Therapeutics Inc. - Overview
Exhibits 132: Lineage Cell Therapeutics Inc. - Product / Service
Exhibits 133: Lineage Cell Therapeutics Inc. - Key offerings
Exhibits 134: Lonza Group Ltd. - Overview
Exhibits 135: Lonza Group Ltd. - Business segments
Exhibits 136: Lonza Group Ltd. - Key news
Exhibits 137: Lonza Group Ltd. - Key offerings
Exhibits 138: Lonza Group Ltd. - Segment focus
Exhibits 139: MEDIPOST Co. Ltd. - Overview
Exhibits 140: MEDIPOST Co. Ltd. - Product / Service
Exhibits 141: MEDIPOST Co. Ltd. - Key offerings
Exhibits 142: Merck and Co. Inc. - Overview
Exhibits 143: Merck and Co. Inc. - Business segments
Exhibits 144: Merck and Co. Inc. - Key news
Exhibits 145: Merck and Co. Inc. - Key offerings
Exhibits 146: Merck and Co. Inc. - Segment focus
Exhibits 147: Mesoblast Ltd. - Overview
Exhibits 148: Mesoblast Ltd. - Product / Service
Exhibits 149: Mesoblast Ltd. - Key offerings
Exhibits 150: Sanofi SA - Overview
Exhibits 151: Sanofi SA - Business segments
Exhibits 152: Sanofi SA - Key news
Exhibits 153: Sanofi SA - Key offerings
Exhibits 154: Sanofi SA - Segment focus
Exhibits 155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 159: ThermoGenesis Holdings Inc. - Overview
Exhibits 160: ThermoGenesis Holdings Inc. - Product / Service
Exhibits 161: ThermoGenesis Holdings Inc. - Key offerings
Exhibits 162: Inclusions checklist
Exhibits 163: Exclusions checklist
Exhibits 164: Currency conversion rates for US$
Exhibits 165: Research methodology
Exhibits 166: Validation techniques employed for market sizing
Exhibits 167: Information sources
Exhibits 168: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global hematopoietic stem cells transplantation (HSCT) market: Athersys Inc., Beike Biotechnology Co. Ltd., bluebird bio Inc., Cellular Biomedicine Group Inc., FUJIFILM Corp., Gamida Cell Ltd., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Mesoblast Ltd., Pluristem Therapeutics Inc., Sanofi SA, Sartorius CellGenix GmbH, Taiga Biotechnologies Inc., Takeda Pharmaceutical Co. Ltd., Talaris Therapeutics Inc., ThermoGenesis Holdings Inc., and AllCells Corp.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing demand for personalized medicine.`

According to the report, one of the major drivers for this market is the availability of technologically advanced equipment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.